Anxiety and Depression addresses assessment and stepped treatment for the most common co-occurring mood and anxiety presentations in clinical practice. This page translates evidence into daily choices: differentiating mixed states from unipolar episodes; recognizing substance-induced symptoms; and sequencing CBT/ACT with pharmacotherapy while protecting sleep and functioning. If you’re comparing events like an anxiety and depression conference, you’ll find pragmatic pathways for first-line care, augmentation, and relapse prevention, with options for perinatal, youth, and late-life populations. Because lifestyle and social determinants shape outcomes, we show how movement, nutrition, and social connection join medication and therapy to shift trajectories, and how registries enable measurement-based care that adapts to response.

Complexity is common: panic with agoraphobia, GAD with insomnia, trauma-related hyperarousal, and overlapping OCD traits. We outline how to stage exposure-based work, manage activation and sexual side effects, and avoid polypharmacy by using clear targets and timelines. Precision thinking helps—pharmacogenomic considerations, side-effect profiles, and comorbidity drive selection and dose. When substance use complicates care, align anxiety treatment with risk-reduction and coordinated SUD support. For exposure protocols and OCD-spectrum specifics, see Exposure and Response Prevention, which complements this page’s broader, transdiagnostic focus.